Furthermore, a specific antifibrotic role for FABP4 as a chaperone of nitro-fatty acids (NO2-FA) is emerging [51], and a recent study demonstrated reversal of bleomycin-induced lung fibrosis in a mouse model with administration of the NO2-FA nitro-oleic acid [52]. Here, FABP4 is linked to pulmonary fibrosis.